Fabric Genomics

Fabric Genomics offers a platform called Fabric Enterprise, which is designed to analyze Next-Generation Sequencing (NGS) data. NGS is a technology that allows for the rapid sequencing of DNA and RNA, which is crucial for identifying genetic variants that may cause diseases. The platform supports various types of genomic tests, including whole genomes, exomes (the part of the genome formed by exons), and panels (specific sets of genes).

The company's business model revolves around providing a software-as-a-service (SaaS) platform. Clients subscribe to Fabric Enterprise to gain access to its powerful AI-driven tools, which significantly reduce the time required to interpret genomic data. This quick turnaround is vital for diagnosing life-threatening conditions where every minute counts. By improving diagnostic yields and reducing the time to diagnosis, Fabric Genomics helps healthcare providers deliver better patient outcomes while also lowering overall healthcare costs.

Fabric Genomics generates revenue through subscription fees for its platform. Additionally, they may offer customized solutions and support services, which can provide additional revenue streams. The company's AI algorithm, Fabric GEM, is a key differentiator, enabling automated reanalysis of undiagnosed cases over time, thus providing ongoing value to their clients.

In summary, Fabric Genomics is transforming the field of genomic testing with its AI-powered platform, helping healthcare providers diagnose genetic illnesses more quickly and accurately.